Drugs / MetfoLiquid GeriaSan®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04590937 | Oct 2020 → Jan 2021 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MetfoLiquid GeriaSan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04590937 ↗ |
| Route | Oral | “Oral solution” NCT04590937 ↗ |